1. Home
  2. MDWD vs BEEP Comparison

MDWD vs BEEP Comparison

Compare MDWD & BEEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDWD
  • BEEP
  • Stock Information
  • Founded
  • MDWD 2000
  • BEEP 2015
  • Country
  • MDWD Israel
  • BEEP United States
  • Employees
  • MDWD N/A
  • BEEP N/A
  • Industry
  • MDWD Medicinal Chemicals and Botanical Products
  • BEEP Blank Checks
  • Sector
  • MDWD Health Care
  • BEEP Finance
  • Exchange
  • MDWD Nasdaq
  • BEEP Nasdaq
  • Market Cap
  • MDWD 184.8M
  • BEEP 178.9M
  • IPO Year
  • MDWD 2014
  • BEEP N/A
  • Fundamental
  • Price
  • MDWD $19.45
  • BEEP $4.02
  • Analyst Decision
  • MDWD Strong Buy
  • BEEP
  • Analyst Count
  • MDWD 1
  • BEEP 0
  • Target Price
  • MDWD $25.00
  • BEEP N/A
  • AVG Volume (30 Days)
  • MDWD 78.0K
  • BEEP 44.2K
  • Earning Date
  • MDWD 03-20-2025
  • BEEP 03-13-2025
  • Dividend Yield
  • MDWD N/A
  • BEEP N/A
  • EPS Growth
  • MDWD N/A
  • BEEP N/A
  • EPS
  • MDWD N/A
  • BEEP N/A
  • Revenue
  • MDWD $19,720,000.00
  • BEEP $35,743,000.00
  • Revenue This Year
  • MDWD $10.15
  • BEEP N/A
  • Revenue Next Year
  • MDWD $25.62
  • BEEP $6.37
  • P/E Ratio
  • MDWD N/A
  • BEEP N/A
  • Revenue Growth
  • MDWD N/A
  • BEEP 21.33
  • 52 Week Low
  • MDWD $11.04
  • BEEP $2.48
  • 52 Week High
  • MDWD $24.00
  • BEEP $4.86
  • Technical
  • Relative Strength Index (RSI)
  • MDWD 55.03
  • BEEP 49.17
  • Support Level
  • MDWD $19.59
  • BEEP $3.84
  • Resistance Level
  • MDWD $20.62
  • BEEP $4.53
  • Average True Range (ATR)
  • MDWD 0.83
  • BEEP 0.36
  • MACD
  • MDWD 0.02
  • BEEP 0.00
  • Stochastic Oscillator
  • MDWD 54.60
  • BEEP 52.63

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

About BEEP Mobile Infrastructure Corporation

Mobile Infrastructure Corp focuses on acquiring, owning, and leasing parking facilities and related infrastructure, including parking lots, parking garages and other parking structures throughout the United States. The company owns forty three parking facilities in twenty one separate markets throughout the United States, with a total of approximately fifteen thousand seven hundred parking spaces. The company derives majority of revenue from Percentage rental income.

Share on Social Networks: